Shares of ICU Medical, Incorporated (NASDAQ:ICUI) have earned an average rating of “Hold” from the six ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $266.00.
Separately, Zacks Investment Research upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $266.00 price objective on the stock in a research report on Tuesday, January 23rd.
Shares of ICU Medical (NASDAQ:ICUI) traded up $1.95 during trading on Monday, reaching $227.15. 77,900 shares of the company were exchanged, compared to its average volume of 91,154. The company has a market capitalization of $4,533.40, a P/E ratio of 147.50, a price-to-earnings-growth ratio of 2.38 and a beta of 0.42. ICU Medical has a 12 month low of $142.01 and a 12 month high of $240.20. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07.
In other ICU Medical news, Director Robert S. Swinney sold 724 shares of the stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $235.00, for a total value of $170,140.00. Following the transaction, the director now directly owns 14,830 shares in the company, valued at $3,485,050. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Scott E. Lamb sold 23,624 shares of the stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $220.00, for a total transaction of $5,197,280.00. Following the completion of the transaction, the chief financial officer now owns 29,723 shares in the company, valued at $6,539,060. The disclosure for this sale can be found here. Insiders sold 25,348 shares of company stock worth $5,582,520 over the last quarter. Insiders own 13.60% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ICUI. Exane Derivatives purchased a new stake in ICU Medical during the 4th quarter worth about $100,000. Israel Discount Bank of New York boosted its stake in shares of ICU Medical by 74.8% in the fourth quarter. Israel Discount Bank of New York now owns 853 shares of the medical instruments supplier’s stock valued at $184,000 after buying an additional 365 shares during the period. First Republic Investment Management Inc. bought a new stake in shares of ICU Medical in the fourth quarter valued at approximately $200,000. Raymond James Trust N.A. bought a new stake in shares of ICU Medical in the fourth quarter valued at approximately $204,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of ICU Medical by 39.2% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 984 shares of the medical instruments supplier’s stock valued at $213,000 after buying an additional 277 shares during the period. Institutional investors and hedge funds own 75.52% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/02/22/icu-medical-incorporated-icui-receives-266-00-average-price-target-from-analysts.html.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.